Once inside a cancer cell, azurin attaches to the DNA-binding domain (DBD) of the tumor-suppressor protein p53 (Figure 6) and increases the intracellular level of the protein by inhibiting the binding of the E3 ubiquitin ligase COP1 to p53 [311]. The gene discussed is TP53; the disease is cancer.